49
Participants
Start Date
November 30, 2011
Primary Completion Date
June 30, 2017
Study Completion Date
June 29, 2017
Bz (Bortezomib)
Bz 1.3 mg/m2 on days +1, +4 and +7. Maintenance therapy and dose reduction pre-specified.
Len (lenalidomide)
"Len at a dose of 6 mg po on day -5 and then 4 mg per day in order to maintain serum levels in the range of 6-12 ng /mL.~Maintenance therapy and dose reduction pre-specified."
Hospital Universitario Ramón y Cajal, Madrid
Medizinische Klinik and Poliklinik II, University Hospital, Würzburg
S Giovanni Battista Hospital, Torino
Azienda Ospedaliera Universitaria di Udine, Udine
Hospital Clinic i Provincial,, Barcelona
Hospital Santa Creu I Sant Pau,, Barcelona
Hospital Gregorio Marañón,, Madrid
Hospital Clinico Universitario Salamanca,, Salamanca
Hospital Universitario Virgen del Rocío,, Seville
Karolinska University Hospital, Huddinge, Stockholm
European Myeloma Network B.V.
NETWORK